An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients

Not Applicable

• Conditions: -G20 Parkinson´s disease; Parkinson´s disease; G20

• Registration Number: PER-031-07
• Lead Sponsor: SOLVAY PHARMACEUTICALS,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-08-13
• Last Update Posted: 4 September 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Subjects who sign the informed consent to participate in the extension study.
2. Subjects who have completed study S308.3.001.

Exclusion Criteria

1. Subjects with abnormal medically relevant findings at the end of the maintenance phase of study S308.3.001.

Study & Design

• Study Type: Interventional
• Study Design: Not specified